Literature DB >> 4304985

Purification and properties of 5-phosphoribosyl pyrophosphate amidotransferase from adenocarcinoma 755 cells.

D L Hill, L L Bennett.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4304985     DOI: 10.1021/bi00829a017

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


× No keyword cloud information.
  16 in total

Review 1.  The clinical pharmacology of 6-mercaptopurine.

Authors:  L Lennard
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  Phase I trial of the combination of 6-methylmercaptopurine riboside and 5-fluorouracil.

Authors:  M C Wiemann; G W Crabtree; A B Weitberg; E N Spremulli; F J Cummings; C Murray; P Calabresi
Journal:  Med Oncol Tumor Pharmacother       Date:  1988

Review 3.  Pathophysiology of hyperuricemia in primary gout.

Authors:  J B Wyngaarden
Journal:  Trans Am Clin Climatol Assoc       Date:  1970

4.  [Effect of benziodaron on purine metabolism in gout patients and healthy subjects].

Authors:  M M Müller; W Bresnik
Journal:  Klin Wochenschr       Date:  1972-11-01

Review 5.  Nucleotide-metabolizing enzymes and lymphocyte differentiation.

Authors:  R W Barton; I Goldschneider
Journal:  Mol Cell Biochem       Date:  1979-12-14       Impact factor: 3.396

6.  Comparative study of 6-mercaptopurine metabolism in human leukemic leukocytes and L1210 cells.

Authors:  T Higuchi; T Nakamura; H Uchino; G Wakisaka
Journal:  Antimicrob Agents Chemother       Date:  1977-10       Impact factor: 5.191

7.  A possible role for 5-phosphoribosyl 1-pyrophosphate in the stimulation of uterine purine nucleotide synthesis in response to oestradiol-17 .

Authors:  J M Oliver
Journal:  Biochem J       Date:  1972-07       Impact factor: 3.857

8.  Genetics of somatic mammalian cells: biochemical genetics of Chinese hamster cell mutants with deviant purine metabolism.

Authors:  D Patterson; F T Kao; T T Puck
Journal:  Proc Natl Acad Sci U S A       Date:  1974-05       Impact factor: 11.205

9.  Purines as 'hyper-repressors' of glucose transport. A role for phosphoribosyl diphosphate.

Authors:  R J Gay; H Amos
Journal:  Biochem J       Date:  1983-07-15       Impact factor: 3.857

10.  IMPDH activity in thiopurine-treated patients with inflammatory bowel disease - relation to TPMT activity and metabolite concentrations.

Authors:  Sofie Haglund; Jan Taipalensuu; Curt Peterson; Sven Almer
Journal:  Br J Clin Pharmacol       Date:  2007-07-27       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.